Business Description
Telo Genomics Corp
NAICS : 621510
SIC : 8681
ISIN : CA88555C1077
Total Employee Number:
6Description
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.74 | |||||
Equity-to-Asset | -0.79 | |||||
Debt-to-Equity | -1.36 | |||||
Debt-to-EBITDA | -0.58 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 4 | |||||
3-Year EPS without NRI Growth Rate | 9.1 | |||||
3-Year FCF Growth Rate | 4.5 | |||||
3-Year Book Growth Rate | -51.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.99 | |||||
9-Day RSI | 39.28 | |||||
14-Day RSI | 42.62 | |||||
3-1 Month Momentum % | 11.36 | |||||
6-1 Month Momentum % | -19.52 | |||||
12-1 Month Momentum % | -41.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.49 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -13272.73 | |||||
ROA % | -260.83 | |||||
ROIC % | -644.83 | |||||
3-Year ROIIC % | 2192.59 | |||||
ROC (Joel Greenblatt) % | -2473.52 | |||||
ROCE % | -4578.43 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -1.87 | |||||
EV-to-EBITDA | -1.91 | |||||
EV-to-FCF | -2.86 | |||||
Earnings Yield (Greenblatt) % | -53.48 | |||||
FCF Yield % | -37.94 |
GF Valueâ„¢
Telo Genomics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Telo Genomics Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.2:1 Stock Split | 2019-11-22 | 0.12 (+13.17%) |
Show
Entries
Guru Commentaries on OTCPK:TDSGF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Telo Genomics Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers